Under construction – not a live service
Sign in
Taking people in FinlandNo phase

Screening pregnant women for risk of placental problems in Finland

Checks how well a pre-eclampsia risk calculator predicts placental problems in pregnant women.

Plain-language title generated from the registry record
Registry title: PEPPI Study: Identification of Women at Risk for Placental Dysfunction

Key facts

Where
Oulu, FinlandSee the site

Where in Finland

  • The Wellbeing Services County of North OstrobothniaOulu, FinlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Oulu University Hospital
Trial code
NCT06115122
Record updated
5 August 2025
Original description
The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population.Read full original descriptionShow less

PEPPI Study: Identification of Women at Risk for Placental Dysfunction During the First and Third Trimesters of Pregnancy

The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population.

Condition or disease: pre-eclampsia, intrauterine growth restriction, polycystic ovary syndrome

Inclusion: Pregnant (first trimester); Understands Finnish; ≥18 years; Signed informed consent; Participates in PEPPI-study (criteria above); Blood samples at first and third trimester of pregnancy; Permits blood sampling from the umbilical cord when the baby is born; Biological father to the child born for the mother who participated in PEPPI study; ≥18 years; Signed informed consent; Born to mother who participated in PEPPI study; Signed informed consent from parent(s); Signed informed consent from parent(s); Mother has blood samples taken at first and third trimester (iron status); Child has blood samples taken at birth and at 3 months of age.

Exclusion: Multiple pregnancy; Miscarriage/termination of the index pregnancy; No first trimester blood sampling; No first or third trimester blood sampling; No umbilical cord blood sample after baby is born; Fathers; Does not understand Finnish; Children; No consent from parent(s); Mother/father declines participation; No consent from parent(s); No blood samples from mother; No blood samples from child.

Mothers.

ClinicalTrials.gov NCT06115122